ALL1 fusion proteins induce deregulation of EphA7 and ERK phosphorylation in human acute leukemias

Proceedings of the National Academy of Sciences of the United States of America

Volumn 104, Issue 36, 2007, Pages 14442-14447

  Nakanishi, Hiroshi ^a   Nakamura, Tatsuya ^a   Canaani, Eli ^b   Croce, Carlo M ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

Eph receptor; Gene regulation; Oncogene

Indexed keywords

5 IODOTUBERCIDIN; COMPLEMENTARY DNA; EPHRIN RECEPTOR; EPHRIN RECEPTOR A7; HYBRID PROTEIN; IMMUNOGLOBULIN G; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; RNA; 5-IODOTUBERCIDIN; DRUG DERIVATIVE; MITOGEN ACTIVATED PROTEIN KINASE; MIXED LINEAGE LEUKEMIA PROTEIN; MLL PROTEIN, HUMAN; ONCOPROTEIN; PROTEIN KINASE INHIBITOR; TUBERCIDIN; UNCLASSIFIED DRUG;

ACUTE LEUKEMIA; APOPTOSIS; ARTICLE; CELL DEATH; CELL STRAIN K 562; CHIMERA; CHROMATIN IMMUNOPRECIPITATION; CHROMOSOME TRANSLOCATION; CONTROLLED STUDY; CYTOGENETICS; ENZYME PHOSPHORYLATION; ERYTHROLEUKEMIA CELL; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; LEUKEMIA; LEUKEMIA CELL LINE; LEUKEMOGENESIS; ONCOGENE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; ACUTE DISEASE; CHROMOSOME 4; DRUG ANTAGONISM; DRUG EFFECT; GENETIC TRANSCRIPTION; GENETICS; GENOME; METABOLISM; PATHOLOGY; PHOSPHORYLATION; PROTEIN BINDING; TUMOR CELL LINE;

ACUTE DISEASE; APOPTOSIS; CELL LINE, TUMOR; CHROMOSOMES, HUMAN, PAIR 4; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOME, HUMAN; HUMANS; LEUKEMIA; MYELOID-LYMPHOID LEUKEMIA PROTEIN; ONCOGENE PROTEINS, FUSION; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN KINASE INHIBITORS; RECEPTOR, EPHA7; TRANSCRIPTION, GENETIC; TUBERCIDIN;

EID: 35448933666     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.0703211104     Document Type: Article

References (24)

1. Pasquale EB (2005) Nat Rev Mol Cell Biol 6:462-475.
2. Easty DJ, Hill SP, Hsu MY, Fallowfield ME, Florenes VA, Herlyn M, Bennett DC (1999) Int J Cancer 84:494-501.
3. Vogt T, Stolz W, Welsh J, Jung B, Kerbel RS, Kobayashi H, Landthaler M, McClelland M (1998) Clin Cancer Res 4:791-797.
4. Lugli A, Spichtin H, Maurer R, Mirlacher M, Kiefer J, Huusko P, Azorsa D, Terracciano L, Sauter G, Kallioniemi OP, et al. (2005) Clin Cancer Res 11:6450-6458.
5. Wu Q, Suo Z, Risberg B, Karlsson MG, Villman K, Nesland JM (2004) Pathol Oncol Res 10:26-33.
6. Walker-Daniels J, Coffman K, Azimi M, Rhim JS, Bostwick DG, Snyder P, Kerns BJ, Waters DJ, Kinch MS (1999) Prostate 41:275-280.
7. Zelinski DP, Zantek ND, Stewart JC, Irizarry AR, Kinch MS (2001) Cancer Res 61:2301-2306.
8. Miyazaki T, Kato H, Fukuchi M, Nakajima M, Kuwano H (2003) Int J Cancer 103:657-663.
9. Kittles RA, Baffoe-Bonnie AB, Moses TY, Robbins CM, Ahaghotu C, Huusko P, Pettaway C, Vijayakumar S, Bennett J, Hoke G, et al. (2006) J Med Genet 43:507-511.
10. Oba SM, Wang YJ, Song JP, Li ZY, Kobayashi K, Tsugane S, Hamada GS, Tanaka M, Sugimura H (2001) Cancer Lett (Shannon, Irel) 164:97-104.
11. Gu Y, Nakamura T, Alder H, Prasad R, Canaani O, Cimino G, Croce CM, Canaani E (1992) Cell 71:701-708.
12. Johansson B, Moorman AV, Haas OA, Watmore AE, Cheung KL, Swanton S, Secker-Walker LM (1998) Leukemia 12:779-787.
13. Aasheim HC, Terstappen LW, Logtenberg T (1997) Blood 90:3613-3622.
14. Nakamura T, Canaani E, Croce CM (2007) Proc Natl Acad Sci USA 104:10980-10985.
15. Thomas M, Gessner A, Vornlocher HP, Hadwiger P, Greil J, Heidenreich O (2005) Blood 106:3559-3566.
16. Zeisig BB, Milne T, Garcia-Cuellar MP, Schreiner S, Martin ME, Fuchs U, Borkhardt A, Chanda SK, Walker J, Soden R, et al. (2004) Mol Cell Biol 24:617-628.
17. Yu C, Subler M, Rahmani M, Reese E, Krystal G, Conrad D, Dent P, Grant S (2003) Cancer Biol Ther 2:544-551.
18. Rubinfeld H, Seger R (2005) Mol Biotechnol 31:151-174.
19. Fox T, Coll JT, Xie X, Ford PJ, Germann UA, Porter MD, Pazhanisamy S, Fleming MA, Galullo V, Su MS, Wilson KP (1998) Protein Sci 11:2249-2255.
20. Armstrong SA, Staunton JE, Silverman LB, Pieters R, den Boer ML, Minden MD, Sallan SE, Lander ES, Golub TR, Korsmeyer SJ (2002) Nat Genet 30:41-47.
21. Rozovskaia T, Ravid-Amir O, Tillib S, Getz G, Feinstein E, Agrawal H, Nagler A, Rappaport EF, Issaeva I, Matsuo Y, et al. (2003) Proc Natl Acad Sci USA 100:7853-7858.
22. Xu S, Robbins D, Frost J, Dang A, Lange-Carter C, Cobb MH (1995) Proc Natl Acad Sci USA 92:6808-6812.
23. Grammer TC, Blenis J (1977) Oncogene 14:1635-1642.
24. Janis LS, Cassidy RM, Kromer LF (1999) J Neurosci 19:4962-4971.